UBS Group’s Equillium EQ Stock Holding History
Bought
Maintained
Sold
Other funds holding EQ
DC
ACM
WP
RCM
VCM
EP
UBS Group's EQ Position: Q1 2026 in Review
UBS Group increased its Equillium (EQ) stake by 1,393% in Q1 2026, buying an estimated $21.1K and bringing the position to 13,740 shares worth $27.5K. The position accounts for ﹤0.01% of the portfolio, ranked #7742.
UBS Group first reported a position in EQ in Q4 2018 and has held it in 21 quarters since. The position peaked at $133K in Q4 2020. 50 funds tracked by Wall St. Rank hold EQ as of Q1 2026.
- UBS Group held 13,740 shares of Equillium worth $27.5K as of Q1 2026.
- UBS Group bought 12,820 Equillium shares in Q1 2026, an estimated $21.1K.
- Equillium made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7742 holding.
- UBS Group first reported a position in Equillium in Q4 2018 and has held it in 21 quarters since.
- UBS Group's Equillium position peaked at $133K in Q4 2020.
- 50 funds tracked by Wall St. Rank held Equillium as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.